Y-mAbs Therapeutics, Inc.
YMAB · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,240 | -$5,196 | -$6,790 | -$6,998 |
| Dep. & Amort. | $53 | $71 | $102 | $121 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,902 | $3,341 | $3,079 | $4,195 |
| Change in WC | $3,876 | -$4,315 | -$1,224 | -$4,378 |
| Other Non-Cash | -$1,940 | -$812 | $2,963 | -$3,605 |
| Operating Cash Flow | $1,651 | -$6,911 | -$1,870 | -$10,665 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$127 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$127 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $332 | $114 | $986 | $979 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $332 | $114 | $986 | $979 |
| Forex Effect | $0 | $0 | -$4 | $2 |
| Net Chg. in Cash | $1,983 | -$6,924 | -$888 | -$9,684 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60,310 | $67,234 | $68,122 | $77,806 |
| End Cash | $62,293 | $60,310 | $67,234 | $68,122 |
| Free Cash Flow | $1,651 | -$7,038 | -$1,870 | -$10,665 |